191 related articles for article (PubMed ID: 15923039)
1. Neuroprotective effect of simvastatin in stroke: a comparison between adult and neonatal rat models of cerebral ischemia.
Cimino M; Balduini W; Carloni S; Gelosa P; Guerrini U; Tremoli E; Sironi L
Neurotoxicology; 2005 Oct; 26(5):929-33. PubMed ID: 15923039
[TBL] [Abstract][Full Text] [Related]
2. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat.
Zhang L; Zhang ZG; Ding GL; Jiang Q; Liu X; Meng H; Hozeska A; Zhang C; Li L; Morris D; Zhang RL; Lu M; Chopp M
Circulation; 2005 Nov; 112(22):3486-94. PubMed ID: 16316970
[TBL] [Abstract][Full Text] [Related]
3. Activation of NF-kB and ERK1/2 after permanent focal ischemia is abolished by simvastatin treatment.
Sironi L; Banfi C; Brioschi M; Gelosa P; Guerrini U; Nobili E; Gianella A; Paoletti R; Tremoli E; Cimino M
Neurobiol Dis; 2006 May; 22(2):445-51. PubMed ID: 16480888
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin reduced ischemic brain injury and perfusion deficits in an embolic model of stroke.
Shabanzadeh AP; Shuaib A; Wang CX
Brain Res; 2005 Apr; 1042(1):1-5. PubMed ID: 15823246
[TBL] [Abstract][Full Text] [Related]
5. [In vivo exploration of cerebral ischemia: use of neuroprotective agents in animal studies].
Lestage P; Lockhart B; Roger A
Therapie; 2002; 57(6):554-63. PubMed ID: 12666263
[TBL] [Abstract][Full Text] [Related]
6. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
7. Post-ischemic delivery of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin protects against focal cerebral ischemia in mice via inhibition of extracellular-regulated kinase-1/-2.
Kilic U; Bassetti CL; Kilic E; Xing H; Wang Z; Hermann DM
Neuroscience; 2005; 134(3):901-6. PubMed ID: 16009498
[TBL] [Abstract][Full Text] [Related]
8. Statins: multiple mechanisms of action in the ischemic brain.
Cimino M; Gelosa P; Gianella A; Nobili E; Tremoli E; Sironi L
Neuroscientist; 2007 Jun; 13(3):208-13. PubMed ID: 17519364
[TBL] [Abstract][Full Text] [Related]
9. Acute lipophilicity-dependent effect of intravascular simvastatin in the early phase of focal cerebral ischemia.
Beretta S; Pastori C; Sala G; Piazza F; Ferrarese C; Cattalini A; de Curtis M; Librizzi L
Neuropharmacology; 2011 May; 60(6):878-85. PubMed ID: 21236270
[TBL] [Abstract][Full Text] [Related]
10. Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat.
Allahtavakoli M; Moloudi R; Arababadi MK; Shamsizadeh A; Javanmardi K
Brain Res; 2009 May; 1271():121-7. PubMed ID: 19332033
[TBL] [Abstract][Full Text] [Related]
11. Dose dependence and therapeutic window for the neuroprotective effects of curcumin in thromboembolic model of rat.
Dohare P; Garg P; Jain V; Nath C; Ray M
Behav Brain Res; 2008 Nov; 193(2):289-97. PubMed ID: 18611416
[TBL] [Abstract][Full Text] [Related]
12. Effect of aminoguanidine on post-ischemic damage in rodent model of stroke.
Vakili A; Zahedi-Khorasani M
Pak J Pharm Sci; 2008 Jan; 21(1):24-8. PubMed ID: 18166515
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotection by pravastatin in acute ischemic stroke in rats.
Berger C; Xia F; Maurer MH; Schwab S
Brain Res Rev; 2008 Jun; 58(1):48-56. PubMed ID: 18035423
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia.
Asahi M; Huang Z; Thomas S; Yoshimura S; Sumii T; Mori T; Qiu J; Amin-Hanjani S; Huang PL; Liao JK; Lo EH; Moskowitz MA
J Cereb Blood Flow Metab; 2005 Jun; 25(6):722-9. PubMed ID: 15716855
[TBL] [Abstract][Full Text] [Related]
15. Treatment with statins in the acute phase of ischemic stroke.
Montaner J
Expert Rev Neurother; 2005 Mar; 5(2):211-21. PubMed ID: 15853491
[TBL] [Abstract][Full Text] [Related]
16. Opioids modulate post-ischemic progression in a rat model of stroke.
Kao TK; Ou YC; Liao SL; Chen WY; Wang CC; Chen SY; Chiang AN; Chen CJ
Neurochem Int; 2008 May; 52(6):1256-65. PubMed ID: 18294735
[TBL] [Abstract][Full Text] [Related]
17. Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activator.
Zhang L; Zhang ZG; Liu X; Hozeska A; Stagliano N; Riordan W; Lu M; Chopp M
Thromb Haemost; 2006 Jan; 95(1):166-73. PubMed ID: 16543976
[TBL] [Abstract][Full Text] [Related]
18. Combined cyclosporine-A and methylprednisolone treatment exerts partial and transient neuroprotection against ischemic stroke.
Yu G; Hess DC; Borlongan CV
Brain Res; 2004 Aug; 1018(1):32-7. PubMed ID: 15262202
[TBL] [Abstract][Full Text] [Related]
19. Brain proteomics identifies potential simvastatin targets in acute phase of stroke in a rat embolic model.
Campos-Martorell M; Salvador N; Monge M; Canals F; García-Bonilla L; Hernández-Guillamon M; Ayuso MI; Chacón P; Rosell A; Alcazar A; Montaner J
J Neurochem; 2014 Jul; 130(2):301-12. PubMed ID: 24661059
[TBL] [Abstract][Full Text] [Related]
20. [Effects of xuezhikang and simvastatin on cerebral ischemia-reperfusion injury in rat].
Zhou FY; Zhang J; Song T; Gao F; Wu JM
Zhongguo Zhong Yao Za Zhi; 2006 Sep; 31(17):1447-50. PubMed ID: 17087088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
